- Hepatitis A Virus
- Hepatitis B Virus
- Hepatitis C Virus
Hepatitis Virus Testing Market size was valued at USD 2.9 billion in 2021, growing at a CAGR of 4.8% from 2022 to 2028. Liver is an essential organ of the body in which performs critical functions that affect the metabolism in the body. Hepatitis refers to the inflammatory condition of the liver and caused by the viral infection or medications. Hepatitis is considered as the sexually transmitted disease. Hepatitis can be classified into hepatitis A, hepatitis, B, hepatitis C, based on the virus. These are confirmed through the laboratory tastings. Various tests are available in the market based on the type of hepatitis. Industry trends in the market are evolving, which will aid players in developing successful long-term strategies. Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. Hepatitis Virus Testing Market research report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.Key Developments: In March 2017, U.S. Food and Drug Administration has approved Siemens Healthineerâ€™s Versant HCV Genotype 2.0 line probe (LiPA) for HCV testing.
Fastest Growing Market
Global hepatitis testing market primarily driven by increase in prevalence viral hepatitis globally. According to World Health Organization, 130 â€“ 150 million people are suffering with th chronic hepatitis c globally and there were many undiagnosed. In addition, increase in healthcare expenditure, lifestyle changes and various initiatives by organizations such as World Health Organization in creating awareness of disease among population projected to boost the market growth. Furthermore, advancements in the diagnostics which quickly produce the test results coupled with increase in investments expected to bolster the market growth over the forecast period. However, lack of awareness among the people in under developing countries and high cost for developing techniques may hamper the market growth over the forecast period.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.